DK1158990T3 - Anvendelse af E5564 til behandlingen af sepsis ved intravenös infusion - Google Patents
Anvendelse af E5564 til behandlingen af sepsis ved intravenös infusionInfo
- Publication number
- DK1158990T3 DK1158990T3 DK00904375T DK00904375T DK1158990T3 DK 1158990 T3 DK1158990 T3 DK 1158990T3 DK 00904375 T DK00904375 T DK 00904375T DK 00904375 T DK00904375 T DK 00904375T DK 1158990 T3 DK1158990 T3 DK 1158990T3
- Authority
- DK
- Denmark
- Prior art keywords
- sepsis
- intravenous infusion
- treatment
- methods
- endotoxemia
- Prior art date
Links
- 206010040047 Sepsis Diseases 0.000 title abstract 2
- 238000001802 infusion Methods 0.000 title abstract 2
- 238000001990 intravenous administration Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 208000037487 Endotoxemia Diseases 0.000 abstract 1
- 206010040070 Septic Shock Diseases 0.000 abstract 1
- 230000001986 anti-endotoxic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000036303 septic shock Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/739—Lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- External Artificial Organs (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11620299P | 1999-01-14 | 1999-01-14 | |
| PCT/US2000/001043 WO2000041703A1 (en) | 1999-01-14 | 2000-01-14 | Administration of an anti-endotoxin drug by intravenous infusion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1158990T3 true DK1158990T3 (da) | 2008-01-28 |
Family
ID=22365882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00904375T DK1158990T3 (da) | 1999-01-14 | 2000-01-14 | Anvendelse af E5564 til behandlingen af sepsis ved intravenös infusion |
Country Status (11)
| Country | Link |
|---|---|
| EP (3) | EP1867336B1 (da) |
| JP (1) | JP2002534471A (da) |
| AT (2) | ATE375798T1 (da) |
| AU (1) | AU2614400A (da) |
| CA (1) | CA2359478A1 (da) |
| CY (1) | CY1108039T1 (da) |
| DE (2) | DE60036790T2 (da) |
| DK (1) | DK1158990T3 (da) |
| ES (1) | ES2291188T3 (da) |
| PT (1) | PT1158990E (da) |
| WO (1) | WO2000041703A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030105033A1 (en) | 2000-06-09 | 2003-06-05 | Rossignol Daniel P. | Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion |
| WO2001093921A2 (en) * | 2000-06-09 | 2001-12-13 | Eisai Co., Ltd. | Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion |
| WO2003013440A2 (en) * | 2001-08-10 | 2003-02-20 | Eisai Co., Ltd. | Treatment and prevention of heat shock protein-associated diseases and conditions |
| US7727974B2 (en) | 2001-08-10 | 2010-06-01 | Eisai R & D Management Co., Ltd. | Methods of reducing the severity of mucositis |
| EP3229813B1 (en) * | 2014-12-12 | 2021-03-24 | The Feinstein Institute for Medical Research | Treatment of hmgb1-mediated inflammation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530113A (en) | 1991-10-11 | 1996-06-25 | Eisai Co., Ltd. | Anti-endotoxin compounds |
| US5750664A (en) * | 1995-06-05 | 1998-05-12 | Eisai Co., Ltd. | Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
-
2000
- 2000-01-14 DK DK00904375T patent/DK1158990T3/da active
- 2000-01-14 ES ES00904375T patent/ES2291188T3/es not_active Expired - Lifetime
- 2000-01-14 EP EP07019438A patent/EP1867336B1/en not_active Expired - Lifetime
- 2000-01-14 DE DE60036790T patent/DE60036790T2/de not_active Expired - Lifetime
- 2000-01-14 DE DE60045750T patent/DE60045750D1/de not_active Expired - Lifetime
- 2000-01-14 JP JP2000593313A patent/JP2002534471A/ja active Pending
- 2000-01-14 PT PT00904375T patent/PT1158990E/pt unknown
- 2000-01-14 AT AT00904375T patent/ATE375798T1/de active
- 2000-01-14 CA CA002359478A patent/CA2359478A1/en not_active Abandoned
- 2000-01-14 AT AT07019438T patent/ATE501760T1/de not_active IP Right Cessation
- 2000-01-14 AU AU26144/00A patent/AU2614400A/en not_active Abandoned
- 2000-01-14 WO PCT/US2000/001043 patent/WO2000041703A1/en not_active Ceased
- 2000-01-14 EP EP00904375A patent/EP1158990B1/en not_active Expired - Lifetime
- 2000-01-14 EP EP10182500A patent/EP2298326A3/en not_active Withdrawn
-
2007
- 2007-12-14 CY CY20071101591T patent/CY1108039T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002534471A (ja) | 2002-10-15 |
| EP2298326A3 (en) | 2011-04-27 |
| EP1158990A1 (en) | 2001-12-05 |
| DE60036790T2 (de) | 2008-07-24 |
| CY1108039T1 (el) | 2013-09-04 |
| EP1867336A2 (en) | 2007-12-19 |
| ES2291188T3 (es) | 2008-03-01 |
| ATE375798T1 (de) | 2007-11-15 |
| DE60045750D1 (de) | 2011-04-28 |
| EP1867336A3 (en) | 2008-04-23 |
| EP1158990B1 (en) | 2007-10-17 |
| PT1158990E (pt) | 2007-12-21 |
| ATE501760T1 (de) | 2011-04-15 |
| WO2000041703A1 (en) | 2000-07-20 |
| EP2298326A2 (en) | 2011-03-23 |
| AU2614400A (en) | 2000-08-01 |
| EP1867336B1 (en) | 2011-03-16 |
| CA2359478A1 (en) | 2000-07-20 |
| EP1158990A4 (en) | 2003-08-13 |
| DE60036790D1 (de) | 2007-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR12C0004I1 (da) | ||
| PE14199A1 (es) | Agonistas de 5-ht1f | |
| ATE246197T1 (de) | Neue heteroaromatische fructose 1,6- bisphosphatase inhibitoren | |
| EA200601554A1 (ru) | Замещенные индол-о-глюкозиды | |
| IS6195A (is) | Notkun á mótefnum gegn CD20 til meðhöndlunar á þegahöfnunarveiki | |
| EA199900758A1 (ru) | Малые молекулы, полезные при лечении воспалительных заболеваний | |
| EA200100411A1 (ru) | Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ | |
| DK1066269T3 (da) | Trisubstituerede 1,3,5-triazinderivater til behandling af HIV-infektioner | |
| DE69826475D1 (de) | Klemmschelle für Schläuche für Infusionszwecke , Transfusionszwecke und dergleichen medizinische Vorrichtungen | |
| EA200200790A1 (ru) | Аминированные производные дигидро-1,3,5-триазина и их применение в терапии | |
| DK1183269T3 (da) | Svækkede mikroorganismer til behandlingen af infektion | |
| ATE350385T1 (de) | Neue aryl fructose-1,6-bisphosphatase inhibitoren | |
| BR0106411B1 (pt) | processo de tratamento do lìquido residual de cromatização. | |
| EA200200348A1 (ru) | Фармацевтические растворы левосимендана | |
| KR910019620A (ko) | 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료 | |
| CY1108039T1 (el) | Χρηση e5564 για την θεραπεια σηψαιμιας με ενδοφλεβια εγχυση | |
| TR200001288T2 (tr) | Östrojen yoksunluğu sendromunun tedavisinde faydalı 2-arilbenzo (b) tiyofenler. | |
| DE69826474D1 (de) | Klemmschelle für Schläuche für Infusionszwecke , Transfusionszwecke und dergleichen medizinische Vorrichtungen | |
| ID25478A (id) | Agonis 5-ht1f | |
| WO2001010384A3 (en) | Method for identifying compounds for treatment of insulin resistance | |
| WO2001093921A3 (en) | Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion | |
| ITRM920305A0 (it) | Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico. | |
| ATE257822T1 (de) | Aminoiminochinon und aminochinon alkaloid verbindungen als caspase inhibitoren | |
| EA199800822A1 (ru) | Способ лечения избыточной агрессии | |
| PT1366033E (pt) | Compostos quimicos |